Grant: Master's Award: Canada Graduate Scholarships
McGill University
$17,500.00
Calwing Liao
EF 2017-18
Résumé
In complex human diseases, only a fraction of phenotypic contributors have been identified. Some of these diseases can be characterized by proteotoxicity due to the loss of protein homeostasis; homeostatic disruptions can be caused by genetic variants. Variants disrupting genes involved in translation—transfer RNA (tRNA) and aminoacyl-tRNA synthetase genes—could lead to mistranslation and exacerbate proteotoxicity. In some hypertriglyceridemia (HTG) individuals—a complex disorder, characterized by extremely elevated plasma triglyceride levels—the driving contributor remains unknown. We hypothesize that proteotoxicity due to genetic variants disrupting genes involved in translation may contribute towards HTG. tRNAseq—a targeted next-generation sequencing (NGS) panel—will be used to study the potential effects tRNA and aminoacyl-tRNA synthetase variation has on high triglycerides. The panel will be used for a matched case-control study involving 300 HTG patients and 300 matched-controls. Sanger sequencing has successfully shown our ability to sequence tRNA genes, given their homology. Samples will be prepared for NGS. Variants will undergo bioinformatic analysis to identify candidates for functional genomics to uncover the effects that mutated tRNA and aminoacyl-tRNA synthetases have on HTG.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
386384
Name
Liao Calwing
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Calwing Liao
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Aminoacyl-Trna Synthetase; Bioinformatics; Genetic Variation; Hypertriglyceridaemia; Mistranslation; Next-Generation Sequencing; Proteotoxicity; Sanger Sequencing; Triglycerides; Trna
Abstract
In complex human diseases, only a fraction of phenotypic contributors have been identified. Some of these diseases can be characterized by proteotoxicity due to the loss of protein homeostasis; homeostatic disruptions can be caused by genetic variants. Variants disrupting genes involved in translation—transfer RNA (tRNA) and aminoacyl-tRNA synthetase genes—could lead to mistranslation and exacerbate proteotoxicity. In some hypertriglyceridemia (HTG) individuals—a complex disorder, characterized by extremely elevated plasma triglyceride levels—the driving contributor remains unknown. We hypothesize that proteotoxicity due to genetic variants disrupting genes involved in translation may contribute towards HTG. tRNAseq—a targeted next-generation sequencing (NGS) panel—will be used to study the potential effects tRNA and aminoacyl-tRNA synthetase variation has on high triglycerides. The panel will be used for a matched case-control study involving 300 HTG patients and 300 matched-controls. Sanger sequencing has successfully shown our ability to sequence tRNA genes, given their homology. Samples will be prepared for NGS. Variants will undergo bioinformatic analysis to identify candidates for functional genomics to uncover the effects that mutated tRNA and aminoacyl-tRNA synthetases have on HTG.
Competitiondate
201712
Approvedterm2
1 yr 0 mth
Pinamesdelim
Liao, Calwing
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~